drugset / Trial / NCT01291732
Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.
RandomizedParallel-groupDouble-blindTreatment
Summary
The Aim of the study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics in Asian healthy males administered a single dose of BI 135585.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 135585 XX | Unknown | 12.5 mg | Oral |
| Subject | BI 135585 XX | Unknown | 50 mg | Oral |
| Subject | BI 135585 XX | Unknown | 200 mg | Oral |
Indications
No indication recorded.